These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6103063)

  • 1. MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
    Björkman S; Lewander T; Zetterström T
    J Pharm Pharmacol; 1980 Apr; 32(4):296-7. PubMed ID: 6103063
    [No Abstract]   [Full Text] [Related]  

  • 2. Tripeptide analogues of melanocyte-stimulating hormone release-inhibiting hormone (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Sievertsson H
    J Med Chem; 1979 Aug; 22(8):931-5. PubMed ID: 40028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides related to melanostatin (Pro-Leu-Gly-NH2) as inhibitors of oxotremorine-induced tremor.
    Björkman S; Castensson S; Lindeke B; Sievertsson H
    Acta Pharm Suec; 1976; 13(4):289-98. PubMed ID: 11638
    [No Abstract]   [Full Text] [Related]  

  • 4. On the optimal dosage of Pro-Leu-Gly-NH2 (MIF) in neuropharmacological tests and clinical use.
    Björkman S; Sievertsson H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Jun; 298(2):79-81. PubMed ID: 18686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
    Voith K
    Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats.
    Hara C; Kastin AJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1785-7. PubMed ID: 2874569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Pro-Leu-Gly-NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine.
    Slater P; Dickinson SL
    J Pharm Pharmacol; 1982 Feb; 34(2):113-5. PubMed ID: 6121869
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide.
    Mycroft FJ; Bhargava HN; Wei ET
    Peptides; 1987; 8(6):1051-5. PubMed ID: 2894644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some analogs of Tyr-MIF-1 affect passive avoidance behavior but not motor activity in rats.
    Hayashi T; Fischman AJ; Kastin AJ; Coy DH
    Pharmacol Biochem Behav; 1984 Nov; 21(5):809-12. PubMed ID: 6151198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.
    Yehuda S; Kastin AJ
    Peptides; 1980; 1(3):243-8. PubMed ID: 6112734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyr-MIF-1 affects passive avoidance behavior but not motor activity in rats.
    Hayashi T; Kastin AJ; Coy DH; Olson RD
    Brain Res Bull; 1983 Dec; 11(6):659-62. PubMed ID: 6140994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tolerance to the pharmacological effects of human beta-endorphin by prolyl-leucyl-glycinamide and cyclo(leucylglycine) in the rat.
    Bhargava HN
    J Pharmacol Exp Ther; 1981 Aug; 218(2):404-8. PubMed ID: 6114170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced response to apomorphine in rats treated with multiple injections of human beta endorphin and its blockade by Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN
    Life Sci; 1981 Nov; 29(19):1945-9. PubMed ID: 6118804
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the effects of Pro-Leu-Gly NH2 and L-leucine on tremorine-induced tremor and rigidity in rats.
    Dickinson SL; Slater P
    J Pharm Pharmacol; 1982 May; 34(5):336-7. PubMed ID: 6123577
    [No Abstract]   [Full Text] [Related]  

  • 19. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats.
    Sandman CA; Kastin AJ
    Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173
    [No Abstract]   [Full Text] [Related]  

  • 20. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
    Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
    Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.